Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-05
Conditions
Interventions
FMX-101, 4% minocycline foam
Vehicle Foam
Locations
36
United States
Glendale, Arizona, United States
Rogers, Arkansas, United States
Oceanside, California, United States
Denver, Colorado, United States
Hialeah, Florida, United States
Miami, Florida, United States
Start Date
May 1, 2016
Primary Completion Date
October 13, 2017
Completion Date
October 13, 2017
Last Updated
January 18, 2022
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT06415305
Lead Sponsor
Vyne Therapeutics Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions